n-(3-(aminomethyl)benzyl)acetamidine has been researched along with atrial natriuretic factor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Hu, X; van Deel, ED; Xu, X; Zhang, P; Zhu, G | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and atrial natriuretic factor
Article | Year |
---|---|
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
Topics: Amidines; Animals; Aortic Diseases; Atrial Natriuretic Factor; Benzylamines; Cardiomegaly; Chronic Disease; Enzyme Inhibitors; Fibrosis; Heart Failure; Hypertension; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Myocardium; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribosomal Protein S6; Systole; TOR Serine-Threonine Kinases; Vasoconstriction | 2007 |